News

Deal Announcements

ActX Adds Venture Capital Equity Funding

Tuesday, July 22, 2014 5:30:00 AM PDT | VentureDeal

   Seattle, Washington  --  Biotechnology information company ActX has received $750,000 in venture capital funding, according to an SEC regulatory filing.

ActX is developing technologies to help make "patient genomic information truly useful in everyday medical practice."

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

ActX is backed by the Alliance of Angels angel group and others.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.